As expiration dates for key patents approach, the blockbuster cancer drug pembrolizumab (Keytruda) reigned as the biggest pharma moneymaker one more time, edging out the diabetes/weight-loss drug ...

An experimental immunotherapy drug called VIR-5500 has driven prostate-specific antigen (PSA) levels down by as much as 99% in some men with metastatic castration-resistant prostate cancer, according ...

By Puyaan Singh and Sahil Pandey March 6 (Reuters) - The U.S. Food and Drug Administration on Friday approved a new ...

Our immune system is great at fighting many types of cancer, but it struggles to see prostate tumors. While new treatments have been game-changers for lung cancer and skin cancer, prostate cancer ...

Learn the key warning signs of prostate cancer that men often overlook. Early awareness can make all the difference.

Researchers found men who ejaculated more often had fewer prostate cancer diagnoses, pointing to a possible biological ...

Metastatic prostate cancer is currently associated with high morbidity and mortality rates. In addition, patients respond very differently to standard treatments such as hormone therapy or radiation ...

The FDA has approved a new formulation of an F 18 prostate-specific membrane antigen imaging agent for men with prostate cancer, according to an industry press release. As Healio previously reported, ...

Prostate tumors contain more microplastics than healthy prostate tissue, researchers from New York University Langone Health ...

Prostate cancer is the most common cancer in American men, with an estimated 333,830 new cases and 36,320 deaths projected for 2026 for the disease, according to the American Cancer ...

NHS staff are going on tour to raise awareness of prostate cancer. The Humber and North Yorkshire Cancer Alliance (HNYCA) is ...